Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/147238
Title: | Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy |
Author: | Ferrusquía Acosta, José Hernández Gea, Virginia Turon, Fanny García Pagán, Juan Carlos |
Keywords: | Estenosi Tromboflebitis Stenosis Thrombophlebitis |
Issue Date: | 7-Oct-2019 |
Publisher: | Elsevier |
Abstract: | We read with interest the study in The Lancet Gastroenterology & Hepatology by Qiuhe Wang and colleagues. 1 This randomised controlled trial aimed to elucidate whether routine stenting plus angioplasty was superior to angioplasty alone for preventing restenosis in patients with Budd-Chiari syndrome with short-length stenosis. The authors found that patients treated with angioplasty plus routine stenting had a lower incidence of restenosis than did patients treated with angioplasty alone, with no differences in survival. Based on these findings, the authors suggested that stenting combined with angioplasty should be used as a first-line invasive treatment in patients with Budd-Chiari syndrome with short-length stenosis. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1016/S2468-1253(19)30296-1 |
It is part of: | The Lancet Gastroenterology & Hepatology, 2019, vol. 4, num. 11, p. 823 |
URI: | http://hdl.handle.net/2445/147238 |
Related resource: | https://doi.org/10.1016/S2468-1253(19)30296-1 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
12474_5888567_thelancetgastrohep-d-19-00513.pdf | 529.24 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License